Transcriptional modulations by RXR agonists are only partially subordinated to PPARα signaling and attest additional, organ-specific, molecular cross-talks

Gene Expression

Volumn 12, Issue 3, 2004, Pages 177-192

  Martin, Pascal G P ^a   Lasserre, Frédéric ^a   Calleja, Cécile ^a,e   Van Es, Armelle ^a,e   Roulet, Alain ^a   Concordet, Didier ^b   Cantiello, Michela ^c   Barnouin, Romain ^a,e   Gauthier, Béatrice ^d   Pineau, Thierry ^a  

^a CEMAGREF   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITY OF TURIN   (Italy)

^d Galderma R and D   (France)

^e INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Cutaneous T cell lymphoma; Fibrate; Microarray; Nuclear receptor; PPAR; PPAR ; Retinoid; Rexinoid; RXR; Vitamin D

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BEXAROTENE; CELL NUCLEUS RECEPTOR; COMPLEMENTARY DNA; DIMER; FENOFIBRATE; HORMONE RECEPTOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RETINOID X RECEPTOR; REXINOID; RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOTYPE; HEART; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE;

MURINAE;

EID: 23944489554     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000005783992098     Document Type: Article

References (47)

1. Abu-Abed, S.; Dolle, P.; Metzger, D.; Beckett, B.; Chambon, P.; Petkovich, M. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hind-brain patterning, vertebral identity, and development of posterior structures. Genes Dev. 15:226-240; 2001.
2. Abu-Abed, S. S.; Beckett, B. R.; Chiba, H.; Chithalen, J. V.; Jones, G.; Metzger, D.; Chambon, P.; Petkovich, M. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha. J. Biol. Chem. 273:2409-2415; 1998.
3. Allegretto, E. A.; Shevde, N.; Zou, A.; Howell, S. R.; Boehm, M. F.; Hollis, B. W.; Pike, J. W. Retinoid X receptor acts as a hormone receptor in vivo to induce a key metabolic enzyme for 1,25-dihydroxyvitamin D3. J. Biol. Chem. 270:23906-23909; 1995.
4. Bettoun, D. J.; Burris, T. P.; Houck, K. A.; Buck, D. W., 2nd; Stayrook, K. R.; Khalifa, B.; Lu, J.; Chin, W. W.; Nagpal, S. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Mol. Endocrinol. 17:2320-2328; 2003.
5. Blue, M. L.; Williams, D. L.; Zucker, S.; Khan, S. A.; Blum, C. B. Apolipoprotein E synthesis in human kidney, adrenal gland, and liver. Proc. Natl. Acad. Sci. USA 80:283-287; 1983.
6. Boehm, M. F.; Zhang, L.; Badea, B. A.; White, S. K.; Mais, D. E.; Berger, E.; Suto, C. M.; Goldman, M. E.; Heyman, R. A. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem. 37:2930-2941; 1994.
7. Boehm, M. F.; Zhang, L.; Zhi, L.; McClurg, M. R.; Berger, E.; Wagoner, M.; Mais, D. E.; Suto, C. M.; Davies, J. A.; Heyman, R. A.; et al. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 38: 3146-3155; 1995.
8. Chen, G.; Paka, L.; Kako, Y.; Singhal, P.; Duan, W.; Pillarisetti, S. A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J. Biol. Chem. 276:49142-49147; 2001.
9. Cherkaoui-Malki, M.; Meyer, K.; Cao, W. Q.; Latruffe, N.; Yeldandi, A. V.; Rao, M. S.; Bradfield, C. A.; Reddy, J. K. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Gene Expr. 9:291-304; 2001.
10. Claudel, T.; Leibowitz, M. D.; Fievet, C.; Tailleux, A.; Wagner, B.; Repa, J. J.; Torpier, G.; Lobaccaro, J. M.; Paterniti, J. R.; Mangelsdorf, D. J.; Heyman, R. A.; Auwerx, J. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc. Natl. Acad. Sci. USA 98:2610-2615; 2001.
11. Costet, P.; Legendre, C.; More, J.; Edgar, A.; Galtier, P.; Pineau, T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J. Biol. Chem. 273:29577-29585; 1998.
12. Duvic, M.; Hymes, K.; Heald, P.; Breneman, D.; Martin, A. G.; Myskowski, P.; Crowley, C.; Yocum, R. C. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results. J. Clin. Oncol. 19:2456-2471; 2001.
13. Esteva, F. J.; Glaspy, J.; Baidas, S.; Laufman, L.; Hutchins, L.; Dickler, M.; Tripathy, D.; Cohen, R.; DeMichele, A.; Yocum, R. C.; Osborne, C. K.; Hayes, D. F.; Hortobagyi, G. N.; Winer, E.; Demetri, G. D. Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer. J. Clin. Oncol. 21: 999 1006; 2003.
14. Forman, B. M.; Umesono, K.; Chen, J.; Evans, R. M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550; 1995.
15. Forman, B. M.; Goode, E.; Chen, J.; Oro, A. E.; Bradley, D. J.; Perlmann, T.; Noonan, D. J.; Burka, L. T.; McMorris, T.; Lamph, W. W.; et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687-693; 1995.
16. Galetto, R.; Albajar, M.; Polanco, J. I.; Zakin, M. M.; Rodriguez-Rey, J. C. Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region. Biochem. J. 357: 521-527; 2001.
17. Gampe, R. T., Jr.; Montana, V. G.; Lambert, M. H.; Miller, A. B.; Bledsoe, R. K.; Milburn, M. V.; Kliewer, S. A.; Willson, T. M.; Xu, H. E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5:545-555; 2000.
18. Germain, P.; Iyer, J.; Zechel, C.; Gronemeyer, H. Coregulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415:187-192; 2002.
19. Itoh, S.; Yoshimura, T.; Iemura, O.; Yamada, E.; Tsujikawa, K.; Kohama, Y.; Mimura, T. Molecular cloning of 25-hydroxyvitamin D-3 24-hydroxylase (Cyp-24) from mouse kidney: Its inducibility by vitamin D-3. Biochim. Biophys. Acta 1264:26-28; 1995.
20. Jackson, J. P.; Ferguson, S. S.; Moore, R.; Negishi, M.; Goldstein, J. A. The constitutive active/androstane receptor regulates phenytoin induction of Cyp2c29. Mol. Pharmacol. 65:1397-1404; 2004.
21. Laffitte, B. A.; Repa, J. J.; Joseph, S. B.; Wilpitz, D. C.; Käst, H. R.; Mangelsdorf, D. J.; Tontonoz, P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA 98:507-512; 2001.
22. Lampen, A.; Meyer, S.; Nau, H. Effects of receptor-selective retinoids on CYP26 gene expression and metabolism of all-trans-retinoic acid in intestinal cells. Drug Metab. Dispos. 29:742-747; 2001.
23. Lee, S. S.; Pineau, T.; Drago, J.; Lee, E. J.; Owens, J. W.; Kroetz, D. L.; Fernandez-Salguero, P. M.; Westphal, H.; Gonzalez, F. J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:3012-3022; 1995.
24. Lehmann, J. M.; Jong, L.; Fanjul, A.; Cameron, J. F.; Lu, X. P.; Haefner, P.; Dawson, M. I.; Pfahl, M. Retinoids selective for retinoid X receptor response pathways. Science 258:1944-1946; 1992.
25. Li, D.; Li, T.; Wang, F.; Tian, H.; Samuels, H. H. Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer. Mol. Cell. Biol. 22:5782-5792; 2002.
26. Loudig, O.; Babichuk, C.; White, J.; Abu-Abed, S.; Mueller, C.; Petkovich, M. Cytochrome P450RAI (CYP26) promoter: A distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. Mol. Endocrinol. 14:1483-1497; 2000.
27. Luu, L.; Ramshaw, H.; Tahayato, A.; Stuart, A.; Jones, G.; White, J.; Petkovich, M. Regulation of retinoic acid metabolism. Adv. Enzyme Regul. 41:159-175; 2001.
28. Mangelsdorf, D. J.; Evans, R. M. The RXR heterodimers and orphan receptors. Cell 83:841-850; 1995.
29. Marikar, Y.; Wang, Z.; Duell, E. A.; Petkovich, M.; Voorhees, J. J.; Fisher, G. J. Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells. J. Invest. Dermatol. 111: 434-439; 1998.
30. Minucci, S.; Leid, M.; Toyama, R.; Saint-Jeannet, J. P.; Peterson, V. J.; Horn, V.; Ishmael, J. E.; Bhattacharyya, N.; Dey, A.; Dawid, I. B.; Ozato, K. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression. Mol. Cell. Biol. 17:644-655; 1997.
31. Mistry, M. J.; Clay, M. A.; Kelly, M. E.; Steiner, M. A.; Harmony, J. A. Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary. Cell. Immunol. 160:14-23; 1995.
32. Mukherjee, R.; Strasser, J.; Jow, L.; Hoener, P.; Paterniti, J. R., Jr.; Heyman, R. A. RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler. Thromb. Vasc. Biol. 18:272-276; 1998.
33. Mukherjee, R.; Davies, P. J.; Crombie, D. L.; Bischoff, E. D.; Cesario, R. M.; Jow, L.; Hamann, L. G.; Boehm, M. F.; Mondon, C. E.; Nadzan, A. M.; Paterniti, J. R., Jr.; Heyman, R. A. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386:407-410; 1997.
34. Niederreither, K.; Vermot, J.; Fraulob, V.; Chambon, P.; Dolle, P. Retinaldehyde dehydrogenase 2 (RALDH2)-independent patterns of retinoic acid synthesis in the mouse embryo. Proc. Natl. Acad. Sci. USA 99:16111-16116; 2002.
35. Ouamrane, L.; Larrieu, G.; Gauthier, B.; Pineau, T. RXR activators molecular signalling: Involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart. Br. J. Pharmacol. 138:845-854; 2003.
36. Pascussi, J. M.; Robert, A.; Nguyen, M.; Walrant-Debray, O.; Garabedian, M.; Martin, P.; Pineau, T.; Saric, J.; Navarro, F.; Maurel, P.; Villarem, M. J. Drug-activated pregnane X receptor enhances CYP24 expression: Possible involvement in drug-induced osteomalacia. J. Clin. Invest. 115:177-186; 2005.
37. Perlmann, T.; Jansson, L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 9:769-782; 1995.
38. Reue, K. L.; Quon, D. H.; O'Donnell, K. A.; Dizikes, G. J.; Fareed, G. C.; Lusis, A. J. Cloning and regulation of messenger RNA for mouse apolipoprotein E. J. Biol. Chem. 259:2100-2107; 1984.
39. Rizvi, N. A.; Marshall, J. L.; Dahut, W.; Ness, E.; Truglia, J. A.; Loewen, G.; Gill, G. M.; Ulm, E. H.; Geiser, R.; Jaunakais, D.; Hawkins, M. J. A Phase I study of LGD1069 in adults with advanced cancer. Clin. Cancer Res. 5:1658-1664; 1999.
40. Takeyama, K.; Kitanaka, S.; Sato, T.; Kobori, M.; Yanagisawa, J.; Kato, S. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277: 1827-1830; 1997.
41. Tzameli, I.; Chua, S. S.; Cheskis, B.; Moore, D. D. Complex effects of rexinoids on ligand dependent activation or inhibition of the xenobiotic receptor, CAR. Nuc1. Recept 1:2; 2003.
42. Vogel, T.; Guo, N. H.; Guy, R.; Drezlich, N.; Krutzsch, H. C.; Blake, D. A.; Panet, A.; Roberts, D. D. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J. Cell. Biochem. 54:299-308; 1994.
43. Willy, P. J.; Umesono, K.; Ong, E. S.; Evans, R. M.; Heyman, R. A.; Mangelsdorf, D. J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9:1033-1045; 1995.
44. Xie, W.; Barwick, J. L.; Simon, C. M.; Pierce, A. M.; Safe, S.; Blumberg, B.; Guzelian, P. S.; Evans, R. M. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14: 3014-3023; 2000.
45. Yamamoto, Y.; Zolfaghari, R.; Ross, A. C. Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic acid metabolism by retinoids and dietary vitamin A in liver of mice and rats. FASEB J. 14: 2119-2127; 2000.
46. Yamazaki, K.; Kuromitsu, J.; Tanaka, I. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator-activated receptor alpha agonists. Biochem. Biophys. Res. Commun. 290: 1114-1122; 2002.
47. Zou, A.; Elgort, M. G.; Allegretto, E. A. Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3. J. Biol. Chem. 272:19027-19034; 1997.